Global Opioid-Induced Constipation Market Report 2016-2019 - Analysis, Technologies & Forecasts - Key Vendors: Abbott Japan, Cubist, Nektar - Research and Markets

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/rt9t4k/opportunityanalyze) has announced the addition of the "OpportunityAnalyzer: Opioid-Induced Constipation - Opportunity Analysis and Forecasts to 2019" report to their offering.

The Opioid-Induced Constipation (OIC) is a new and rapidly establishing market currently dominated by OTC laxatives set to undergo substantial growth between 2014 and 2019.

Key Topics Covered:

  • Overview of OIC, including epidemiology, etiology, pathophysiology, symptoms, diagnosis, and treatment guidelines.
  • Annualized OIC therapeutics market revenue, annual cost of therapy and treatment usage pattern data from 2014 and forecast for seven years to 2019.
  • Key topics covered include strategic competitor assessment, market characterization, unmet needs, clinical trial mapping and implications for the OIC therapeutics market.
  • Pipeline analysis: comprehensive data split across different phases, emerging novel trends under development, and detailed analysis of late-stage pipeline drugs.

Benefits of this Report:

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline. Additionally a list of acquisition targets included in the pipeline product company list.
  • Develop business strategies by understanding the trends shaping and driving the global OIC therapeutics market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global OIC therapeutics market in future.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track drug sales in the global OIC therapeutics market from 2014-2019.

Companies Mentioned:

  • Abbott Japan
  • Allergan
  • AstraZeneca
  • Cubist
  • Forest Laboratories
  • Ironwood Pharmaceuticals
  • Nektar
  • Mundipharma
  • Ono Pharmaceuticals
  • Progenics
  • Purdue Pharma
  • Shionogi
  • S.L.A. Pharma
  • Sucampo
  • Synergy Pharmaceuticals
  • Takeda
  • Theravance
  • Valeant Pharmaceuticals

Report Structure:

1.1 List of Tables

1.2 List of Figures

2 Introduction

3 Disease Overview

4 Potential Patient Population

5 Current Treatment Options

6 Unmet Needs Assessment and Opportunity Analysis

7 R&D Strategies

8 Pipeline Assessment

9 Pipeline Valuation Analysis

10 Appendix

For more information visit http://www.researchandmarkets.com/research/rt9t4k/opportunityanalyze

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology